Celularity (CELU) Current Deferred Revenue (2020 - 2026)
Celularity (CELU) posted Current Deferred Revenue of $5.13 million for Q2 2026, up 46.4% from $3.5 million a year earlier and up 27.5% from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Current Deferred Revenue (2020 - 2026) Analysis & Trends
At the end of FY2025, Celularity's Current Deferred Revenue came in at $5.26 million, up 48.8% from FY2024.
- Annual Current Deferred Revenue has increased for four consecutive years, with a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
- In prior years, Celularity's Current Deferred Revenue was $3.53 million in FY2024 (+24.6%), $2.83 million in FY2023 (+24.7%), $2.27 million in FY2022 (+3.5%) and $2.2 million in FY2021 (-54.5%).
- Quarterly Current Deferred Revenue has run from a low of $2.03 million in Q3 2021 to a high of $5.58 million in Q3 2025 over five years.
- On a year-over-year basis, Current Deferred Revenue has increased in each of the last 16 quarters, with growth averaging 35.8% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2025, with growth of 51.2%; the weakest was Q4 2021, with a decline of 54.5%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $4.03 million (Q1 2026), $5.26 million (Q4 2025) and $5.58 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Celularity | 30.75 Mn | 23.50 Mn | 3.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.13 Mn |
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 2.46 Mn |
| Jun 30, 2023 | 2.31 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 2.24 Mn |
| Jun 30, 2022 | 2.23 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.03 Mn |
API Access
Celularity Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();